This Web site is developed and maintained under the editorial direction of diagnosticimaging.com, the Web site of Diagnostic Imaging magazine and its related publications.
It is the goal of this Web site to be the Web’s most comprehensive and up-to-date source of information on radiofrequency ablation and other energy-based tumor ablation therapies.
Material for this site is developed by physicians and medical journalists. Material also comes from the pages of Diagnostic Imaging magazine and its related publications, from Oncology News International magazine, and from reports published at www.diagnosticimaging.com.
Editorial director:
John C. Hayes, john.hayes@cmpmedica.com
Contributing editors:
Sarah Jersild, sjersild@gmail.com
H.A. Abella, habella@cmp.com
Copy editors:
Kathleen Lawrence
Frances Taylor
Web Master:
DIWebMaster@cmp.comEditorial questions: Inquiries should be directed to the Editor, Diagnostic Imaging, 600 Harrison St., San Francisco, CA 94107, 415/947-6472, john.hayes@cmpmedica.com.
DISCLOSURE: The editorial material on this Web site is published solely by CMP Healthcare Media Group LLC, the publisher of Diagnostic Imaging. CMP Media LLC does not endorse the appropriateness of or are responsible for any actions taken by third parties on the basis of material available at this Web site.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.